nach oben

Erschienen in:

01.09.2023 | Clinical study

Delayed ADEs post-COVID-19 vaccination in patients with systemic sclerosis

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Delayed adverse drug events (ADEs) after COVID-19 vaccination do not appear to be more frequent in patients with systemic sclerosis (SSc) than in patients with other systemic autoimmune and inflammatory disorders (SAIDs) or in healthy controls (HCs). These were the findings of a global study published in Rheumatology International . …

Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort Rheumatology International : 15 Sep 2023. Available from: URL: https://doi.org/10.1007/s00296-023-05441-z

Titel: Delayed ADEs post-COVID-19 vaccination in patients with systemic sclerosis
Publikationsdatum: 01.09.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-46734-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Delayed ADEs post-COVID-19 vaccination in patients with systemic sclerosis

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Crotalidae-immune-fab-(equine)/crotalidae-polyvalent-immune-fab(ovine)

Antithymocyte-globulin/mycophenolate/prednisone

Nitroglycerin

Multiple drugs

Axicabtagene-ciloleucel/dexamethasone

Tapentadol has similar incidence of opioid-related ADEs to oxycodone